Clinical trial
Genetic Predictors of Lithium Response in Bipolar Disorder
NCT00252577 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00252577 |
|---|---|
| Title | Genetic Predictors of Lithium Response in Bipolar Disorder |
| Official title | Genetic Studies of Psychiatric Illness |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Status | Completed |
| Study type | Observational |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Lithium treatment |
| Enrollment | 130 |
| Start date | Oct 1, 2005 |
| Primary completion | Mar 1, 2016 |
| Completion | May 1, 2016 |
| First posted | Nov 11, 2005 |
| Last update posted | Jan 29, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: